GARDEN BIOPHARMA
30040112.424.37% ( +0.52 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: GARDEN BIOPHARMA(300401) the Revenue is 276.88 M (-15.17%);the EBIT is 66.73 M (-38.79%);the EPS is 0.09 (-50%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.28B15.17%
----
----
EBIT
0.07B38.79%
----
----
EPS
0.0950.00%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf